• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

THE ROLE OF IMMUNE SYSTEM AND DIFFERENTIATION AT MICROENVIRNMENT INVOLVED IN INVASION AND METASTASIS OF PANCREATIC CANCER

Research Project

Project/Area Number 08671475
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Digestive surgery
Research InstitutionOSAKA CITY UNIVERSITY

Principal Investigator

SAWADA Tetsuji  OSAKA CITY UNIVERSITY MEDICAL SCHOOL,FIRST DEPARTMENT OF SURGERY,INSTRUCTOR, 医学部, 助手 (60275253)

Project Period (FY) 1996 – 1998
Project Status Completed (Fiscal Year 1998)
Budget Amount *help
¥1,200,000 (Direct Cost: ¥1,200,000)
Fiscal Year 1998: ¥600,000 (Direct Cost: ¥600,000)
Fiscal Year 1997: ¥600,000 (Direct Cost: ¥600,000)
KeywordsPancreatic cancer / Invasion and metastasis / Microenvirnment / Cytokine / Immune system / ICAM-1 / 浸潤、転移
Research Abstract

The cytokines production, TN7F- alpha and IL-1 beta were detected during the mixed leukocytes tumor cell culture (MLTC) (co-culture of pancreatic cancer cells with perpheral blood mononuclear leukocytes ; MNL from healthy volunteers), and these cytokines were mainly produced by monocytes. They may activate endothelial cells and induce ELAM-1 expression on them which will play an important role in cancer cell-endothelial cell adhesion and liver metastasis. Consequently, the expression of adhesion molecules involved in immune reaction on cancer cells was investigated using three human pancreatic cancer cells, SW1990 (highly liver metastatic), CAPAN-2 (low metastatic) and PANC-1 (no metastatic). While the expressions of HLA class I antigen were detected on all cells, ICAM-1 expression was low in SW1990 contrary to its metastatic potentia. According to this result, MNL adhesion to SW1990 and cytotoxicity of SW1990 by MNL were minimum and cell escape of SW1990 from immune effector cells suc … More h as NK, LAK cells which use ICAM-1/LFA-1 system in cancer cell recognition must be involved in development of metastasis. Next investigating the relationship between ICAM-1 expression and clinicopathological factors by immunochemical study on surgical specimens, histological type and existence of lymphnode's metastasis or invasion to portal system have no relationship, but liver metastasis were highly found in ICAM-1 negative cases compared with positive case. ICAM-1 expressions on cancer cell surface were increased in dose dependent fashion by treatment with TNF- alpha except for SW1990, on the other hand TGF- beta1) significantly decreased ICAM-1 expression on all cells and lymphocyte's adhesion and cytotoxicity to cancer cells. Finally as other functional effects of TGF- beta1 in invasion and metastasis were investigated, it increase protenase productions such as MMP-2 and u-PA, in vitro invasion and in vivo liver metastasis of metastatic SW1990 and CAPAN-2. These findings suggested that TGF- beta1 may play important roles in liver metastasis of pancreatic cancer not only by suppressing host immune function but also by making cancer cells escape from effector cells through inhibiting ICAM-1 expression and increasing invasive and metastatic potential in autocrine or paracrine fashion. New therapeutic application to inhibit liver metastasis using neubizing TGF- beta1 antibody or drugs to decrease the production of TGF- beta1 should be investigated in future study. Less

Report

(4 results)
  • 1998 Annual Research Report   Final Research Report Summary
  • 1997 Annual Research Report
  • 1996 Annual Research Report
  • Research Products

    (12 results)

All Other

All Publications (12 results)

  • [Publications] 澤田 鉄二: "膵癌肝転移におけるELAM-1接着とサイトカインの関与および糖鎮誠・阻害剤による転移抑制" 日本消化器外科学会雑誌. 29・4. 74-78 (1996)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] YOSHIYUKI KAWAZOE: "Role of wokirase-Type plasmnoger uctivator and inmoitory ettect of protease inhibitor in invasion and metascasis of puwmith canw" Interrafonel Journal of Ortology. 10. 983-987 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] 澤田 鉄二: "消化器癌の転移におけるICAM-1発現の意義" 消化器癌の発生と進展. 9. 31-35 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Atsushi Yamhito: "Radioimmunotherapy of orthotopically transplanted pancreatic canser with l-131-labeled chimeric monoclonal antibody Nd2" Oncology Reports. in press.

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] SAWADA T.: "Role of ELAM-1 binding and cytokines in liver metastasis of pancreatic cancer and possible therapeutic application of a glycosylation inhibitor" The Japanese Journal of Gastroenterological Surgery. 29 (4). 868-872 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] KAWAZOE Y.: "Role of urokinase-type plasminogen activator and inhibitory effect in invasion and metastasis of pancreatic cancer" International Journal of Oncology. 10. 983-987 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] SAWADA T.: "The role of ICAM-1 expression in metastasis of gastrointestinal cancers" Journal of Japanese Society for Gastroenterological Carcinogenesis. 9. 31-35 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] YAMAMOT A.: "Radioimmunotherapy of orthotopically transplanted pancreatic cancer with 131I-labeled chimeric monoclonal antibody Nd2" Oncology Reports. (in press). (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Atsushi Yamamoto: "Radioimmunotherapy of orthotopically transplanted pancreatic cancer with 131I-labeled chimeric monoclonal antibody Nd2" Oncology Reports. in press.

    • Related Report
      1998 Annual Research Report
  • [Publications] 澤田 鉄二: "消化器癌の転移におけるICAM-1発現の意義" 消化器癌の発生と進展. 9. 31-35 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] YOSHIYUKI KAWAZOE: "Role of urokinase-type plasminogen activator and inhibitory effect of protease inhibitor in invasion and metastasis of pancreatic cancer" International Journal of Oncology. 10. 983-987 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] 澤田鉄二: "膵癌肝転移におけるELAM-1接着とサイトカインの関与および糖鎖合成阻害剤による転移抑制" 日本消化器外科学会雑誌. 29・4. 74-78 (1996)

    • Related Report
      1996 Annual Research Report

URL: 

Published: 1997-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi